Related Articles
Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer
Effect of gefitinib on serum EGFR and CYFRA21‑1 in patients with advanced non‑small cell lung cancer
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Serum levels of candidate microRNA diagnostic markers differ among the stages of non‑small‑cell lung cancer
Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy